Biolinq
M. Andrew (Drew) Woodmansee has a long and distinguished career in legal affairs. M. Andrew (Drew) began their career in 1996 as an Associate at Seyfarth Shaw. M. Andrew (Drew) then moved to DLA Piper (formerly Rudnick & Wolfe) as an Associate in 1997. In 1998, they became an Associate at Heller Ehrman. In 2000, they joined Morrison & Foerster LLP as a Partner, and served as the founding partner of the firm's Intellectual Property Practice Group. In 2016, they moved to JONES DAY® as a Partner in the firm's Intellectual Property Practice Group. In 2019, they joined Hooper, Lundy & Bookman, PC as a Partner and served as the founding partner of HLB's Intellectual Property practice group. In 2021, they became the Vice President of Legal Affairs at Biolinq, where they lead the legal and IP groups. Additionally, they have served on the Board of Directors at Trilibis Mobile since 2002.
M. Andrew (Drew) Woodmansee received their J.D. from Notre Dame Law School between 1993 and 1996. M. Andrew (Drew) also obtained a B.A. in Political Science (Government and International Studies) from the University of Notre Dame between 1989 and 1993.
Biolinq
2 followers
Biolinq develops a wearable biosensor platform that is capable of measuring blood level information. Under the leadership of Jared Tangney and Josh Windmiller, Biolinq is redefining how biomedical innovations can be imagined and commercialized. While conducting his post-doctoral research at the University of California, San Diego in the laboratoryfor NanoBioElectronics, Josh saw the potential to bring nanotechnology to the medical world. Combining forces with Jared, a Ph.D. in Biomedical Engineering, the two saw the opportunity to bring their minimally-invasive technology to the diabetes space. Finally, people with diabetes will have a better CGM experience that is not only more affordable but also pain-free.